Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 5:14 pm Purchase |
2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
Laurion Capital Management LP | 3,170,803 9.000% |
3,170,803 (New Position) |
Filing History |
| 2022-11-04 4:00 pm Purchase |
2022-10-25 | 13G | Pyxis Oncology, Inc. PYXS |
TANG CAPITAL PARTNERS LP | 1,981,426 5.600% |
1,981,426 (New Position) |
Filing History |
| 2022-05-23 06:15 am Purchase |
2022-03-31 | 13D | Pyxis Oncology, Inc. PYXS |
Lara Sullivan, M.D. | 3,466,895 9.600% |
1,153,531 (+49.86%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
RA Capital Management, L.P. | 2,282,173 7.000% |
367,239 (+19.18%) |
Filing History |
| 2022-02-14 08:51 am Purchase |
2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
RTW Investments, LP | 2,120,760 6.500% |
2,120,760 (New Position) |
Filing History |
| 2022-02-11 4:35 pm Purchase |
2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
Bayer World Investments B.V. | 2,742,338 8.400% |
2,742,338 (New Position) |
Filing History |
| 2022-02-11 4:26 pm Purchase |
2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
PFIZER INC PFE |
2,991,522 9.130% |
2,991,522 (New Position) |
Filing History |
| 2021-12-20 5:23 pm Purchase |
2021-12-10 | 13G | Pyxis Oncology, Inc. PYXS |
BIOTECHNOLOGY VALUE FUND L P | 1,791,351 5.500% |
1,791,351 (New Position) |
Filing History |
| 2021-10-25 4:34 pm Purchase |
2021-10-13 | 13G | Pyxis Oncology, Inc. PYXS |
RA Capital Management, L.P. | 1,914,934 5.800% |
1,914,934 (New Position) |
Filing History |
| 2021-10-21 6:52 pm Purchase |
2021-10-13 | 13D | Pyxis Oncology, Inc. PYXS |
Lara Sullivan, M.D. | 2,313,364 6.660% |
2,313,364 (New Position) |
Filing History |